相关实验视频
Updated: Jan 11, 2026

Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
氧化应激和神经元变化:线粒体功能障碍是难治性的关键因素 - - 一个叙述性综述
Muhammad Liaquat Raza1, Mustafa Hussain Imam2, Warisha Zehra3
1Department of Infection Prevention Control, Ministry of National Guard Health Affairs (MNGHA), Riyadh, Saudi Arabia; King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia; King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.
线粒体功能障碍是抗药性症 (DRE) 的关键因素,影响发作和治疗抵抗. 准线粒体为DRE管理提供了有希望的新诊断和治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 线粒体生物学 线粒体生物学
- 的研究研究.
背景情况:
- 耐药性 (DRE) 影响了全球三分之一的患者,带来了重大的治疗挑战.
- 目前对DRE的治疗已经停滞不前,需要新的机制性见解和治疗方法.
- 线粒体功能障碍越来越被认为是病发病,耐药性和疾病进展的关键因素.
研究的目的:
- 审查临床前和临床证据,将线粒体功能障碍与联系起来.
- 检查与线粒体相关的神经元脆弱性的关键机制,包括氧化应激,线粒体和线粒体透性过渡孔口.
- 分析线粒体功能障碍的临床前模型,并评估DRE的新兴线粒体为中心的治疗策略.
主要方法:
- 临床前和临床研究的叙述性综述.
- 对中线粒体功能障碍的证据分析.
- 评估临床前模型和治疗干预措施.
主要成果:
- 线粒体功能障碍导致神经元过度兴奋,氧化损伤和中细胞死亡.
- 线粒体DNA突变和异质体可能作为发作发作,严重程度和治疗反应的生物标志物.
- 针对线粒体健康的新兴疗法显示出对DRE管理的希望.
结论:
- 线粒体功能障碍是DRE的中心机制,影响发作和治疗结果.
- 以线粒体为中心的方法对DRE的诊断和治疗都有很大的前景.
- 对线粒体通路的进一步研究对于推进DRE疗法至关重要.
相关概念视频
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Disorders of the Nervous Tissue
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Antiepileptic Drugs: Glutamate Antagonists
Mitochondrial Membranes
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...

